A "Negative" Home Study in a Woman With Classic Insomnia
Ms. L is a 58-year-old woman with a BMI of 33, treated hypertension, and a six-year history of insomnia. She describes a 45-minute sleep latency, three awakenings per night, and total sleep time of about 5.5 hours. Insomnia Severity Index is 21. STOP-BANG is 3 (snoring, daytime tiredness, age over 50, hypertension). A home sleep apnea test was ordered and returned an AHI of 4.6 based on 3.2 hours of recording time, with oximetry valid for 1.9 hours and only about 20% of the recording spent supine. She asks whether she needs a CPAP and wants her zolpidem refilled indefinitely.
1. How do you interpret the adequacy and meaning of this home sleep apnea test, and what is your recommendation?
Read the worked answer
The result should not be treated as a clean rule-out.
- Recording time: A technically adequate HSAT generally requires roughly 4 or more hours of recording; 3.2 hours is short, and valid oximetry for only 1.9 hours is thinner still.
- Positional bias: With only ~20% supine sleep, a largely supine-dependent obstruction could be missed; the AHI reflects mostly non-supine sleep.
- Pretest probability: Snoring, BMI 33, hypertension, and age over 50 mean a negative HSAT has limited negative predictive value in this patient.
- Symptom overlap: Her sleepiness may be explained by 5.5 hours of fragmented sleep, but that does not exclude OSA.
Recommendation: do not declare OSA absent and do not start PAP on this study. Route the result back to the ordering provider with a request for either an in-laboratory polysomnogram or a repeat HSAT with attention to supine time, while proceeding with behavioral insomnia treatment in parallel rather than sequentially.
2. She wants a long-term zolpidem prescription and asks why she should bother with "talking therapy." How do you counsel her?
Read the worked answer
Respect the request, then give her the comparative picture.
- Acknowledge that the medication has helped her fall asleep and that stopping abruptly is not the goal of this conversation.
- Explain that CBT-I is recommended as first-line for chronic insomnia because the benefit is sustained after treatment ends, whereas hypnotics lose efficacy with continued nightly use and carry risks of tolerance, dependence, and next-day impairment - relevant to driving.
- Note that her insomnia is chronic and likely maintained by behaviors (time in bed, bedtime variability, worry about sleep), which a pill does not address. Behavioral treatment also fits better with the possibility of untreated OSA, where sedatives can worsen airway collapsibility and blunt arousal.
- Offer a concrete, non-threatening plan: keep the current prescription stable for now, coordinate with the prescriber, and start CBT-I concurrently. Set measurable goals (sleep latency, wake after sleep onset, nights per week of medication use) rather than promising a taper.
- Document her preferences and goals, including that she values the medication.